These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9097267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM, Esforzado N, Martínez J, Roselló L, Veciana L, Modol J, Casellas J, Pons M, de Las Cuevas X, Piera J, Oliva JA, Costa J, Barrera JM, Bruguera M.
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
    Saracco G, Borghesio E, Mesina P, Solinas A, Spezia C, Macor F, Gallo V, Chiandussi L, Donada C, Donadon V, Spirito F, Mangia A, Andriulli A, Verme G, Rizzetto M.
    J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
    Saracco G, Ciancio A, Ghisetti V, Rocca G, Cariti G, Andreoni M, Tabone M, Roffi L, Calleri G, Ballaré M, Terreni N, Sartori M, Tappero GF, Traverso A, Poggio A, Orani A, Maggi G, Di Napoli A, Arrigoni A, Rizzetto M, North West Italian Hepatological Group.
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):149-55. PubMed ID: 11246614
    [Abstract] [Full Text] [Related]

  • 11. Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant alpha-interferon.
    Bresci G, Parisi G, Bertoni M, Scatena F, Capria A.
    J Viral Hepat; 2000 Jan; 7(1):75-8. PubMed ID: 10718946
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment.
    Gürsoy M, Gür G, Arslan H, Ozdemir N, Boyacioglu S.
    J Viral Hepat; 2001 Jan; 8(1):70-7. PubMed ID: 11155154
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.
    Brouwer JT, Nevens F, Kleter B, Elewaut A, Adler M, Brenard R, Chamuleau RA, Michielsen PP, Pirotte J, Hautekeete ML, Weber J, Bourgeois N, Hansen BE, Bronkhorst CM, ten Kate FJ, Heijtink RA, Fevery J, Schalm SW.
    J Hepatol; 1998 Jun; 28(6):951-9. PubMed ID: 9672169
    [Abstract] [Full Text] [Related]

  • 15. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C, Strohmeyer G, Heintges T, Peter K, Göpfert E.
    Hepatogastroenterology; 1998 Jun; 45(21):797-804. PubMed ID: 9684137
    [Abstract] [Full Text] [Related]

  • 16. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL, Izopet J, Galindo-Migeot V, Lauwers-Cances V, Zarski JP, Seigneurin JM, Dussaix E, Voigt JJ, Selves J, Barange K, Puel J, Pascal JP.
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [Abstract] [Full Text] [Related]

  • 17. The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: a multicentre, prospective study.
    Degos F, Pol S, Chaix ML, Laffitte V, Buffet C, Bernard PH, Degott C, Carnot F, Riffaud PC, Chevret S.
    Nephrol Dial Transplant; 2001 May; 16(5):1017-23. PubMed ID: 11328909
    [Abstract] [Full Text] [Related]

  • 18. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L, Cavalletto L, Casarin C, Bonetti P, Bernardinello E, Pontisso P, Donada C, Belussi F, Martinelli S, Alberti A.
    Ann Intern Med; 1996 Jun 15; 124(12):1058-60. PubMed ID: 8633819
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.
    Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Bréchot C.
    Kidney Int; 1995 May 15; 47(5):1412-8. PubMed ID: 7637270
    [Abstract] [Full Text] [Related]

  • 20. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.
    Mizokami M, Orito E, Gibo Y, Suzuki K, Ohba K, Ohno T, Lau JY.
    Liver; 1996 Feb 15; 16(1):23-7. PubMed ID: 8868074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.